Combination of imatinib mesylate with lithium chloride and medroxyprogesterone acetate is highly active in Ishikawa endometrial carcinoma in vitro

Journal of Gynecologic Oncology

Volumn 22, Issue 4, 2011, Pages 225-232

  Bilir, Ayhan ^a   Erguven, Mine ^b   Ermis, Ezgi ^c   Sencan, Mine ^a   Yazihan, Nuray ^c  

^a ISTANBUL UNIVERSITY   (Turkey)

^b ISTANBUL YENI YUZYIL UNIVERSITY   (Turkey)

^c ANKARA UNIVERSITY   (Turkey)

Author keywords

Endometrial cancer; Imatinib mesylate; Lithium chloride; Medroxyprogesterone acetate; Midkine

Indexed keywords

CASPASE 3; IMATINIB; LITHIUM CHLORIDE; MEDROXYPROGESTERONE ACETATE;

APOPTOSIS; ARTICLE; CELL CULTURE; CELL CYCLE ARREST; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL PROLIFERATION; CELL STRUCTURE; DRUG EFFICACY; DRUG POTENTIATION; ENDOMETRIUM CARCINOMA; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY;

EID: 84857672358     PISSN: 20050380     EISSN: 20050399     Source Type: Journal    
DOI: 10.3802/jgo.2011.22.4.225     Document Type: Article

References (25)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009. CA Cancer J Clin 2009;59:225-249.
2. Di Cristofano A, Ellenson LH. Endometrial carcinoma. Annu Rev Pathol 2007;2:57-85.
3. Abal M, Planaguma J, Gil-Moreno A, Monge M, Gonzalez M, Baro T, et al. Molecular pathology of endometrial carcinoma: transcriptional signature in endometrioid tumors. Histol Histopathol 2006;21:197-204.
4. Lax SF. Molecular genetic pathways in various types of endometrial carcinoma: from a phenotypical to a molecular-based classification. Virchows Arch 2004;444:213-223.
5. Waller CF. Imatinib mesylate. Recent Results Cancer Res 2010;184:3-20.
6. Salvatierra A, Tarrats A, Gomez C, Sastre JM, Balana C. A case of c-kit positive high-grade stromal endometrial sarcoma responding to Imatinib Mesylate. Gynecol Oncol 2006;101:545-547.
7. Mitsuhashi T, Nakayama M, Sakurai S, Fujimura M, Shimizu Y, Ban S, et al. KIT-negative undifferentiated endometrial sarcoma with the amplified epidermal growth factor receptor gene showing a temporary response to imatinib mesylate. Ann Diagn Pathol 2007;11:49-54.
8. Ha HT, Lee JS, Urba S, Koenig RJ, Sisson J, Giordano T, et al. A phase II study of imatinib in patients with advanced anaplastic thyroid cancer. Thyroid 2010;20:975-980.
9. Ustach CV, Huang W, Conley-LaComb MK, Lin CY, Che M, Abrams J, et al. A novel signaling axis of matriptase/ PDGF-D/β-PDGFR in human prostate cancer. Cancer Res 2010;70:9631-9640.
10. Vidal F, de Araujo WM, Cruz AL, Tanaka MN, Viola JP, Morgado-Diaz JA. Lithium reduces tumorigenic potential in response to EGF signaling in human colorectal cancer cells. Int J Oncol 2011;38:1365-1373.
11. Cho YJ, Kim JH, Yoon J, Cho SJ, Ko YS, Park JW, et al. Constitutive activation of glycogen synthase kinase-3beta correlates with better prognosis and cyclin-dependent kinase inhibitors in human gastric cancer. BMC Gastroenterol 2010;10:91.
12. Bilir A, Erguven M, Yazihan N, Aktas E, Oktem G, Sabanci A. Enhancement of vinorelbine-induced cytotoxicity and apoptosis by clomipramine and lithium chloride in human neuroblastoma cancer cell line SH-SY5Y. J Neurooncol 2010;100:385-395.
13. Zhu H, Han B, Pan X, Qi H, Xu L. Thiazolidenediones induce tumour-cell apoptosis through the Akt-GSK3 β pathway. J Clin Pharm Ther 2011 Mar 16 [Epub]. http://dx.doi. org/10.1111/j.1365-2710.2011.01251.x.
14. Nishio S, Koyanagi T, Miyabe K, Kuromatsu H. Two cases of multidrug-resistant recurrent endometrial cancer successfully treated with medroxyprogesterone acetate (MPA). Gan To Kagaku Ryoho 2010;37:735-738.
15. Cade TJ, Quinn MA, Rome RM, Neesham D. Progestogen treatment options for early endometrial cancer. BJOG 2010; 117:879-884.
16. Madeddu C, Maccio A, Panzone F, Tanca FM, Mantovani G. Medroxyprogesterone acetate in the management of cancer cachexia. Expert Opin Pharmacother 2009;10:1359-1366.
17. Yang S, Thiel KW, Leslie KK. Progesterone: the ultimate endometrial tumor suppressor. Trends Endocrinol Metab 2011;22:145-152.
18. Wang Y, van der Zee M, Fodde R, Blok LJ. Wnt/B-catenin and sex hormone signaling in endometrial homeostasis and cancer. Oncotarget 2010;1:674-684.
19. Muramatsu T. Midkine, a heparin-binding cytokine with multiple roles in development, repair and diseases. Proc Jpn Acad Ser B Phys Biol Sci 2010;86:410-425.
20. Zhang L, Rees MC, Bicknell R. The isolation and long-term culture of normal human endometrial epithelium and stroma: expression of mRNAs for angiogenic polypeptides basally and on oestrogen and progesterone challenges. J Cell Sci 1995;108:323-331.
21. Miller MC 3rd, Johnson KR, Willingham MC, Fan W. Apoptotic cell death induced by baccatin III, a precursor of paclitaxel, may occur without G(2)/M arrest. Cancer Chemother Pharmacol 1999;44:444-452.
22. Bilir A, Altinoz MA, Erkan M, Ozmen V, Aydiner A. Autophagy and nuclear changes in FM3A breast tumor cells after epirubicin, medroxyprogesterone and tamoxifen treatment in vitro. Pathobiology 2001;69:120-126.
23. Erguven M, Yazihan N, Aktas E, Sabanci A, Li CJ, Oktem G, et al. Carvedilol in glioma treatment alone and with imatinib in vitro. Int J Oncol 2010;36:857-866.
24. Orrenius S, Nicotera P, Zhivotovsky B. Cell death mechanisms and their implications in toxicology. Toxicol Sci 2011; 119:3-19.
25. Rawnaq T, Kunkel M, Bachmann K, Simon R, Zander H, BrandlS, et al. Serum midkine correlates with tumor progression and imatinib response in gastrointestinal stromal tumors. Ann Surg Oncol 2011;18:559-565.